Come join others currently navigating treatment in our weekly Virtual Support Groups! See times and register here.
Giredestrant Reduces Recurrence Risk More Than Tamoxifen, Aromatase Inhibitors
moderators
Posts: 9,937
Giredestrant Reduces Recurrence Risk More Than Tamoxifen, Aromatase Inhibitors
Dec 22, 2025
Results from the lidERA trial suggest that giredestrant could be a new standard of care for early-stage hormone receptor-positive breast cancer. Read more…
Tagged:
0
Categories
Join Us on Zoom: Upcoming virtual support groups. Read more...
Share more about you! Fill out your profile.